The store will not work correctly when cookies are disabled.
9-(2-chlorophenethyl)-6-[(2-chlorophenethyl)thio]-9H-purine
ID: ALA4763745
PubChem CID: 162661176
Max Phase: Preclinical
Molecular Formula: C20H16Cl2N4S
Molecular Weight: 415.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Clc1ccccc1CCSc1ncnc2c1ncn2Cc1ccccc1Cl
Standard InChI: InChI=1S/C20H16Cl2N4S/c21-16-7-3-1-5-14(16)9-10-27-20-18-19(23-12-24-20)26(13-25-18)11-15-6-2-4-8-17(15)22/h1-8,12-13H,9-11H2
Standard InChI Key: IBAQPXBXKVTMDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
23.1234 -26.1501 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1223 -26.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8303 -27.3786 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8286 -25.7412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5372 -26.1465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5420 -26.9651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3220 -27.2135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.7994 -26.5484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3143 -25.8890 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8261 -24.9240 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
23.1172 -24.5176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4107 -24.9283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7018 -24.5218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7029 -23.7054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9948 -23.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2874 -23.7098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2924 -24.5312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0011 -24.9339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0072 -25.7511 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.5790 -27.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3793 -28.1545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6312 -28.9303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4306 -29.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9748 -28.4849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7140 -27.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9151 -27.5442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0859 -29.5389 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
18 19 1 0
7 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
22 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 415.35 | Molecular Weight (Monoisotopic): 414.0473 | AlogP: 5.52 | #Rotatable Bonds: 6 |
Polar Surface Area: 43.60 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 3.05 | CX LogP: 5.99 | CX LogD: 5.99 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.31 | Np Likeness Score: -1.53 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |